Atlanta, GA, August 9, 2002 --- MDdatacor, inc., a medical informatics company that rapidly identifies patient populations for clinical trials, approved therapeutics and medical devices, today announced it reached a key milestone of having one million patient records under management. MDdatacor creates information products from this data that physicians, pharmaceutical companies and medical device manufacturers use to improve patient care and accelerate the development of new, potentially lifesaving drugs and medical devices.

"This is a significant accomplishment for our company and demonstrates the value that physician practices see in the decision support tools we provide them as part of our MDinsight™ service," commented Blake Whitney, MDdatacor chairman, president and chief executive officer. "We expect the number of records in our database to grow dramatically over the next six months as our co-marketing arrangement with DIANON Systems (NASDAQ:DIAN) and other marketing initiatives begin to take effect."

Physician practices provide MDdatacor with electronic copies of patient chart information, such as transcribed progress notes, lab results and demographic information. MDdatacor uses a patent-pending technology to convert this information into a searchable clinical database. Physicians can search the online database to identify patients who may need additional medical follow-up, qualify for a clinical trial, or may be medically indicated for drug or device therapy. Using MDdatacor's de-identified database information, pharmaceutical firms and medical device manufacturers can accelerate clinical trial screening and enrollment processes, and reduce the time and cost of new product and drug development.

MDdatacor began marketing its services to cardiology practices in January 2002 and to urology and gastroenterology practices through its marketing partner DIANON Systems this past May. MDdatacor expects to enter the oncology physician market early in 2003.

"The ability to efficiently aggregate and search medical record information can have a profound impact on clinical trial design and trial recruitment efficiency," commented Jonathan Seltzer, M.D., a board-certified cardiologist and chief executive officer of Applied Clinical Intelligence, LLC, a Philadelphia-based firm that focuses predominately on data safety monitoring, drug development, and the application of large clinical databases to streamline the pharmaceutical research processes. "Further, MDdatacor's technology may help us better understand why certain patient populations have different outcomes. This offers the potential for improving clinical trial processes, drug development and patient safety."